# Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

> **NCT06067802** · PHASE2 · SUSPENDED · sponsor: **Jerry Vockley, MD, PhD** · enrollment: 8 (estimated)

## Conditions studied

- Medium-chain Acyl-CoA Dehydrogenase Deficiency

## Interventions

- **DRUG:** Triheptanoin

## Key facts

- **NCT ID:** NCT06067802
- **Lead sponsor:** Jerry Vockley, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-08
- **Primary completion:** 2028-08
- **Final completion:** 2029-03
- **Target enrollment:** 8 (ESTIMATED)
- **Why stopped:** Study has been temporarily stopped until another study is completed. Data from the other study may inform changes to this study.
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06067802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06067802, "Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06067802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*